OneTest for Cancer

🔬 What Makes Some Cancers More Aggressive Than Others?
New research from Virginia Tech suggests that cancer aggressiveness may depend not only on the type of cancer, but also on characteristics of the cancer cells themselves. Researchers found that smaller cancer cells with abnormal chromosome numbers grew faster, were more invasive, and showed greater resistance to treatment.
These findings, published in Cancer Biology ("Cell and Nuclear Size Is Associated with Chromosomal Instability and Tumorigenicity in Cancer Cells That Undergo Whole Genome Doubling") and PNAS ("Oxidative Stress and Serum Deprivation Influence the Evolution of Newly Formed Tetraploid Cells During Tumorigenesis"), highlight how subtle cellular changes can influence cancer progression.
At OneTest, we believe that understanding biological changes before symptoms appear is key to a more proactive approach to health. By analyzing multiple cancer-related biomarkers and applying AI-powered risk assessment, OneTest is designed to identify patterns associated with cancer risk earlier.

🔍 Cancer screening saves lives — and the numbers prove it.
According to the latest report from the American Association for Cancer Research (AACR) Cancer Progress Report 2025, screening and prevention efforts have helped prevent 4.75 million cancer deaths in the United States over the past several decades. In colorectal cancer alone, 79% of lives saved were linked to screening and removal of precancerous polyps.
The challenge? Many cancers still have no recommended routine screening tests, and too many people miss the opportunity for early detection. That's why researchers are investing in new technologies, including AI-powered risk assessment, minimally invasive blood tests, and advanced imaging, to identify cancer earlier—before symptoms appear.
Early detection can mean:
✅ More treatment options
✅ Less aggressive treatment
✅ Better outcomes
✅ Greater peace of mind
The future of cancer care isn't just treating cancer earlier—it's identifying risk sooner and helping people take action before cancer advances.

Today, on National Cancer Survivors Day, we celebrate the strength, courage, and resilience of millions of cancer survivors and their families.

Every survivor's journey is a powerful reminder of the importance of hope, support, and continued progress in cancer care.

To all survivors: your determination inspires us every day. 💗

Recent headlines have sparked discussions about multi-cancer early detection (MCED) tests. One important point often gets lost in the conversation:
Not all blood-based cancer tests work the same way.
One of the key limitations of ctDNA-based testing is that early-stage cancers may not release enough tumor DNA into the bloodstream to be detected. As a result, ctDNA-based tests can miss some cancers at the stage when early detection matters most.
Protein biomarkers, however, can provide sufficient biological information for analysis even when ctDNA levels are too low to detect. By analyzing multiple biomarkers simultaneously, AI-powered approaches can identify subtle patterns associated with cancer risk at an earlier stage.
The future of medicine is detecting the body's earliest signals of disease — before enough tumor DNA is present to be detected.

Cancer isn't just a disease of older adults — and the numbers are proving it. 📊 Early-onset cancer cases (adults under 50) are rising by 1–2% every year, and researchers predict a 30% jump between 2019 and 2030. Oncologists are seeing more patients in their 30s and 40s with breast, colorectal, and head and neck cancers. So what's behind the rise? Possible factors include: 🔸 Chronic inflammation from stress, obesity, or low physical activity 🔸 Changes to the gut microbiome from processed foods or microplastics 🔸 Reproductive factors 🔸 Inequities in healthcare access Here's what experts agree on: knowing your family history and paying attention to symptoms matter — especially when many young adults fall below the standard screening age. That's exactly why early cancer risk detection tools like OneTest exist. One test. Multiple cancers. Peace of mind. 💙 👉 Learn more at onetestforcancer.com 📖 Source: UChicago Medicine, "Why are more young people getting cancer?" (August 2024) — uchicagomedicine.org

This is why we do what we do. Listen to Jimmy's story about his screening at FDIC 2 years ago and how it led to the detection of his Stage 2 cancer. Let us know how we can help you get to with .

https://youtu.be/B_SdZpXCAJI?si=Np-nN_RldmuzlqMM

Fire Engineering 2 likes. "How Early Cancer Screening @ FDIC May have Helped to Save the Life of this Firefighter"

We have had a great time with some friends new and old at ! Even got to speak to a few people who detected the first signs of their cancer with OneTest!

We are here and ready to screen tomorrow at FDIC! Booth #11110 Indiana Convention Center across from the Podcast Booth.

Can you feel the excitement? FDIC is next week and we cannot wait to see you in Indianapolis! Come visit Team OneTest at Booth #11110 in the Indiana Convention Center across from the Podcast Booth to find out what's new from OneTest. Want to try a OneTest for yourself? We will be drawing them in the booth on Thursday!